{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:33:43Z","timestamp":1767184423851,"version":"build-2238731810"},"reference-count":39,"publisher":"Walter de Gruyter GmbH","issue":"10","funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003968","name":"Iranian National Science Foundation","doi-asserted-by":"crossref","award":["93042561"],"award-info":[{"award-number":["93042561"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -Synuclein fibrillation is now regarded as a major pathogenic process in Parkinson\u2019s disease and its proteinaceous deposits are also detected in other neurological disorders including Alzheimer's disease. Therefore anti-amyloidegenic compounds may delay or prevent the progression of synucleinopathies disease. Molecular chaperones are group of proteins which mediate correct folding of proteins by preventing unsuitable interactions which may lead to aggregation. The objective of this study was to investigate the anti-amyloidogenic effect of molecular chaperone artemin on\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein. As the concentration of artemin was increased up to 4\u00a0\u03bcg\/ml, a decrease in fibril formation of\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein was observed using thioflavin T (ThT) fluorescence and congo red (CR) assay. Transmission electron microscopy (TEM) images also demonstrated a reduction in fibrils in the presence of artemin. The secondary structure of\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein was similar to its native form prior to fibrillation when incubated with artemin. A cell-based assay has shown that artemin inhibits\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein aggregation and reduce cytotoxicity, apoptosis and reactive oxygen species (ROS) production. Our results revealed that artemin has efficient chaperon activity for preventing\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein fibril formation and toxicity.\n                  <\/jats:p>","DOI":"10.1515\/hsz-2019-0446","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T09:34:50Z","timestamp":1594978490000},"page":"1143-1151","source":"Crossref","is-referenced-by-count":7,"title":["Anti-amyloidogenic effect of artemin on\n                    <i>\u03b1<\/i>\n                    -synuclein"],"prefix":"10.1515","volume":"401","author":[{"given":"Narges","family":"Marvastizadeh","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Biological Sciences , Tarbiat Modares University , P.O. Box 14115-175 , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3615-5683","authenticated-orcid":false,"given":"Bahareh","family":"Dabirmanesh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Biological Sciences , Tarbiat Modares University , P.O. Box 14115-175 , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza H.","family":"Sajedi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Biological Sciences , Tarbiat Modares University , P.O. Box 14115-175 , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khosro","family":"Khajeh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Biological Sciences , Tarbiat Modares University , P.O. Box 14115-175 , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"2023040406532142611_j_hsz-2019-0446_ref_001_w2aab3b7c30b1b6b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Ahsan, N., Mishra, S., Jain, M.K., Surolia, A., and Gupta, S. (2015). Curcumin pyrazole and its derivative (N-(3-nitrophenylpyrazole) curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of wild type and mutant \u03b1-synuclein. Sci. Rep. 5: 9862, https:\/\/doi.org\/10.1038\/srep09862.","DOI":"10.1038\/srep09862"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_002_w2aab3b7c30b1b6b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Anguiano, M., Nowak, R.J., and Lansbury, P.T. (2002). Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41: 11338\u201311343, https:\/\/doi.org\/10.1021\/bi020314u.","DOI":"10.1021\/bi020314u"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_003_w2aab3b7c30b1b6b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Arispe, N. (2004). Architecture of the Alzheimer's A\u03b2P ion channel pore. J. Membr. Biol. 197: 33\u201348, https:\/\/doi.org\/10.1007\/s00232-003-0638-7.","DOI":"10.1007\/s00232-003-0638-7"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_004_w2aab3b7c30b1b6b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248\u2013254, https:\/\/doi.org\/10.1006\/abio.1976.9999.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_005_w2aab3b7c30b1b6b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Breydo, L., Wu, J.W., and Uversky, V.N. (2012). \u03b1-Synuclein misfolding and Parkinson's disease. Biochim. Biophys. Acta. 1822: 261\u2013285, https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.002.","DOI":"10.1016\/j.bbadis.2011.10.002"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_006_w2aab3b7c30b1b6b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Chen, T., Villeneuve, T.S., Garant, K.A., Amons, R., and MacRae, T.H. (2007). Functional characterization of artemin, a ferritin homolog synthesized in Artemia embryos during encystment and diapause. FEBS J. 274: 1093\u20131101, https:\/\/doi.org\/10.1111\/j.1742-4658.2007.05659.x.","DOI":"10.1111\/j.1742-4658.2007.05659.x"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_007_w2aab3b7c30b1b6b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Congdon, E.E., Necula, M., Blackstone, R.D., and Kuret, J. (2007). Potency of a tau fibrillization inhibitor is influenced by its aggregation state. Arch. Biochem. Biophys. 465: 127\u2013135, https:\/\/doi.org\/10.1016\/j.abb.2007.05.004.","DOI":"10.1016\/j.abb.2007.05.004"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_008_w2aab3b7c30b1b6b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Conte, A., Pellegrini, S., and Tagliazucchi, D. (2003). Synergistic protection of PC12 cells from \u03b2-amyloid toxicity by resveratrol and catechin. Brain Res. Bull. 62: 29\u201338, https:\/\/doi.org\/10.1016\/j.brainresbull.2003.08.001.","DOI":"10.1016\/j.brainresbull.2003.08.001"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_009_w2aab3b7c30b1b6b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Cox, D., Carver, J.A., and Ecroyd, H. (2014). Preventing \u03b1-synuclein aggregation: the role of the small heat-shock molecular chaperone proteins. Biochim. Biophys. Acta. 1842: 1830\u20131843, https:\/\/doi.org\/10.1016\/j.bbadis.2014.06.024.","DOI":"10.1016\/j.bbadis.2014.06.024"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_010_w2aab3b7c30b1b6b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Dehay, B., Bourdenx, M., Gorry, P., Przedborski, S., Vila, M., Hunot, S., Singleton, A., Olanow, C.W., Merchant, K.M., Bezard, E., et al. (2015). Targeting \u03b1-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations. Lancet Neurol 14: 855\u2013866, https:\/\/doi.org\/10.1016\/S1474-4422(15)00006-X.","DOI":"10.1016\/S1474-4422(15)00006-X"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_011_w2aab3b7c30b1b6b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Fink, A.L. (1998). Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3: R9\u2013R23, http:\/\/doi.org\/10.1016\/S1359-0278(98)00002-9.","DOI":"10.1016\/S1359-0278(98)00002-9"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_012_w2aab3b7c30b1b6b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Fink, A.L. (2006). The aggregation and fibrillation of \u03b1-synuclein. Acc. Chem. Res. 39: 628\u2013634l, https:\/\/doi.org\/10.1021\/ar050073t.","DOI":"10.1021\/ar050073t"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_013_w2aab3b7c30b1b6b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Friesen, E.L., De Snoo, M.L., Rajendran, L., Kalia, L.V., and Kalia, S.K. (2017). Chaperone-based therapies for disease modification in Parkinson's disease. Park. Dis. 2017: 5015307, https:\/\/doi.org\/10.1155\/2017\/5015307.","DOI":"10.1155\/2017\/5015307"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_014_w2aab3b7c30b1b6b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Giehm, L., Lorenzen, N., and Otzen, D.E. (2011). Assays for \u03b1-synuclein aggregation. Methods 53: 295\u2013305, https:\/\/doi.org\/10.1016\/j.ymeth.2010.12.008.","DOI":"10.1016\/j.ymeth.2010.12.008"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_015_w2aab3b7c30b1b6b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Hansen, C., Angot, E., Bergstr\u00f6m, A.L., Steiner, J.A., Pieri, L., Paul, G., Outeiro, T.F., Melki, R., Kallunki, P., and Fog, K. (2011). \u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest 121: 715\u2013725, https:\/\/doi.org\/10.1172\/JCI43366.","DOI":"10.1172\/JCI43366"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_016_w2aab3b7c30b1b6b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Hassani, L., and Sajedi, R.H. (2013). Effect of artemin on structural transition of \u03b2-lactoglobulin. Spectrochim Acta Part A Mol. Biomol. Spectrosc 105: 24\u201328, https:\/\/doi.org\/10.1016\/j.saa.2012.12.003.","DOI":"10.1016\/j.saa.2012.12.003"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_017_w2aab3b7c30b1b6b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Honarmand, S., Dabirmanesh, B., Amanlou, M., and Khajeh, K. (2019). The interaction of several herbal extracts with \u03b1-synuclein: Fibril formation and surface plasmon resonance analysis. PLoS One 14: e0217801, https:\/\/doi.org\/10.1371\/journal.pone.0217801.","DOI":"10.1371\/journal.pone.0217801"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_018_w2aab3b7c30b1b6b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Jellinger, K.A. (2001). Cell death mechanisms in neurodegeneration. J. Cell. Mol. Med. 5: 1\u201317, https:\/\/doi.org\/10.1111\/j.1582-4934.2001.tb00134.x.","DOI":"10.1111\/j.1582-4934.2001.tb00134.x"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_019_w2aab3b7c30b1b6b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Jellinger, K.A. (2010). Basic mechanisms of neurodegeneration: a critical update. J. Cell. Mol. Med. 14: 457\u2013487, https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01010.x.","DOI":"10.1111\/j.1582-4934.2010.01010.x"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_020_w2aab3b7c30b1b6b1ab2b2c20Aa","unstructured":"Khosravi, Z., Khalili, M.A.N., Moradi, S., Hassan Sajedi, R., and Zeinoddini, M. (2018). The molecular chaperone artemin efficiently blocks fibrillization of TAU protein in vitro. Cell. J. 19: 569, https:\/\/doi.org\/10.22074\/cellj.2018.4510."},{"key":"2023040406532142611_j_hsz-2019-0446_ref_021_w2aab3b7c30b1b6b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680, https:\/\/doi.org\/10.1038\/227680a0.","DOI":"10.1038\/227680a0"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_022_w2aab3b7c30b1b6b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"Maiti, P., Manna, J., Veleri, S., and Frautschy, S. (2014). Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed. Res. Int. 2014: 14, https:\/\/doi.org\/10.1155\/2014\/495091.","DOI":"10.1155\/2014\/495091"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_023_w2aab3b7c30b1b6b1ab2b2c23Aa","doi-asserted-by":"crossref","unstructured":"Melki, R. (2018). Alpha-synuclein and the prion hypothesis in Parkinson's disease. Rev. Neurol 174: 644\u2013652, https:\/\/doi.org\/10.1016\/j.neurol.2018.08.002.","DOI":"10.1016\/j.neurol.2018.08.002"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_024_w2aab3b7c30b1b6b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Narkiewicz, J., Giachin, G., and Legname, G. (2014). In vitro aggregation assays for the characterization of \u03b1-synuclein prion-like properties. Prion 8: 19\u201332, https:\/\/doi.org\/10.4161\/pri.28125.","DOI":"10.4161\/pri.28125"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_025_w2aab3b7c30b1b6b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Porat, Y., Abramowitz, A., and Gazit, E. (2006). Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug. Des. 67: 27\u201337, https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00318.x.","DOI":"10.1111\/j.1747-0285.2005.00318.x"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_026_w2aab3b7c30b1b6b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"Sashourpour, M., Zahri, S., Radjabian, T., Ruf, V., Pan-Montojo, F., and Morshedi, D. (2017). A study on the modulation of alpha-synuclein fibrillation by Scutellaria pinnatifida extracts and its neuroprotective properties. PLoS One. 12: e0184483, https:\/\/doi.org\/10.1371\/journal.pone.0184483.","DOI":"10.1371\/journal.pone.0184483"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_027_w2aab3b7c30b1b6b1ab2b2c27Aa","doi-asserted-by":"crossref","unstructured":"Selkoe, D.J. (2004). Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell. Biol. 6: 1054\u20131061, https:\/\/doi.org\/10.1038\/ncb1104-1054.","DOI":"10.1038\/ncb1104-1054"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_028_w2aab3b7c30b1b6b1ab2b2c28Aa","doi-asserted-by":"crossref","unstructured":"Shahangian, S.S., Rasti, B., Hasan Sajedi, R., Khodarahmi, R., Taghdir, M., and Ranjbar, B. (2011). Artemin as an efficient molecular chaperone. Protein J. 30: 549\u2013557, https:\/\/doi.org\/10.1007\/s10930-011-9359-4.","DOI":"10.1007\/s10930-011-9359-4"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_029_w2aab3b7c30b1b6b1ab2b2c29Aa","doi-asserted-by":"crossref","unstructured":"Stefani, M. (2012). Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits. Prog. Neurobiol 99: 226\u2013245, https:\/\/doi.org\/10.1016\/j.pneurobio.2012.03.002.","DOI":"10.1016\/j.pneurobio.2012.03.002"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_030_w2aab3b7c30b1b6b1ab2b2c30Aa","doi-asserted-by":"crossref","unstructured":"Surmeier, D.J., Obeso, J.A., and Halliday, G.M. (2017). Parkinson's disease is not simply a prion disorder. J. Neurosci. 37: 9799\u2013807, https:\/\/doi.org\/10.1523\/JNEUROSCI.1787-16.2017.","DOI":"10.1523\/JNEUROSCI.1787-16.2017"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_031_w2aab3b7c30b1b6b1ab2b2c31Aa","doi-asserted-by":"crossref","unstructured":"Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., and Nurmi, A. (2017). Protein misfolding in neurodegenerative diseases: implications and strategies. Transl. Neurodegener 6: 6, https:\/\/doi.org\/10.1186\/s40035-017-0077-5.","DOI":"10.1186\/s40035-017-0077-5"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_032_w2aab3b7c30b1b6b1ab2b2c32Aa","doi-asserted-by":"crossref","unstructured":"Uversky, V.N. (2002) What does it mean to be natively unfolded? Eur. J. Biochem. 269: 2\u201312, https:\/\/doi.org\/10.1046\/j.0014-2956.2001.02649.x.","DOI":"10.1046\/j.0014-2956.2001.02649.x"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_033_w2aab3b7c30b1b6b1ab2b2c33Aa","doi-asserted-by":"crossref","unstructured":"Uversky, V.N. and Fink, A.L. (2004). Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta. 1698: 131\u2013153, https:\/\/doi.org\/10.1016\/j.bbapap.2003.12.008.","DOI":"10.1016\/j.bbapap.2003.12.008"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_034_w2aab3b7c30b1b6b1ab2b2c34Aa","doi-asserted-by":"crossref","unstructured":"Uversky, V.N., Li, J., and Fink, A.L. (2001a). Pesticides directly accelerate the rate of \u03b1-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett. 500: 105\u2013108, https:\/\/doi.org\/10.1016\/s0014-5793(01)02597-2.","DOI":"10.1016\/S0014-5793(01)02597-2"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_035_w2aab3b7c30b1b6b1ab2b2c35Aa","doi-asserted-by":"crossref","unstructured":"Uversky, V.N., Li, J., and Fink, A.L. (2001b). Evidence for a partially folded intermediate in \u03b1-synuclein fibril formation. J. Biol. Chem. 276: 10737\u201310744, https:\/\/doi.org\/10.1074\/jbc.M010907200.","DOI":"10.1074\/jbc.M010907200"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_036_w2aab3b7c30b1b6b1ab2b2c36Aa","doi-asserted-by":"crossref","unstructured":"Vashist, S., Cushman, M., and Shorter, J. (2010). Applying Hsp104 to protein-misfolding disorders. Biochem. Cell. Biol. 88: 1\u201313.","DOI":"10.1139\/O09-121"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_037_w2aab3b7c30b1b6b1ab2b2c37Aa","doi-asserted-by":"crossref","unstructured":"Warner, A.H., Brunet, R.T., MacRae, T.H., and Clegg, J.S. (2004). Artemin is an RNA-binding protein with high thermal stability and potential RNA chaperone activity. Arch. Biochem. Biophys. 424: 189\u2013200, https:\/\/doi.org\/10.1016\/j.abb.2004.02.022.","DOI":"10.1016\/j.abb.2004.02.022"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_038_w2aab3b7c30b1b6b1ab2b2c38Aa","doi-asserted-by":"crossref","unstructured":"Xu, L. and Pu, J. (2016). Alpha-synuclein in Parkinson's disease: from pathogenetic dysfunction to potential clinical application. Park. Dis. 2016: 10, https:\/\/doi.org\/10.1155\/2016\/1720621.","DOI":"10.1155\/2016\/1720621"},{"key":"2023040406532142611_j_hsz-2019-0446_ref_039_w2aab3b7c30b1b6b1ab2b2c39Aa","doi-asserted-by":"crossref","unstructured":"Zhang, H., Xu, L.-Q., and Perrett, S. (2011). Studying the effects of chaperones on amyloid fibril formation. Methods 53: 285\u2013294, https:\/\/doi.org\/10.1016\/j.ymeth.2010.11.009.","DOI":"10.1016\/j.ymeth.2010.11.009"}],"container-title":["Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/bchm\/401\/10\/article-p1143.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/hsz-2019-0446\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/hsz-2019-0446\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T04:46:19Z","timestamp":1680583579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/hsz-2019-0446\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":39,"aliases":["10.1515\/hsz-2020-0446"],"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,7,16]]},"published-print":{"date-parts":[[2020,9,25]]}},"alternative-id":["10.1515\/hsz-2019-0446"],"URL":"https:\/\/doi.org\/10.1515\/hsz-2019-0446","relation":{},"ISSN":["1437-4315","1431-6730"],"issn-type":[{"value":"1437-4315","type":"electronic"},{"value":"1431-6730","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,16]]}}}